Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
暂无分享,去创建一个
C. Chen | Shi-Ming Chen | Fen Li | Lei Wang | B. Xiao | Mengyuan Dai | Man Li | Anyuan Zheng | Di Yu | Zhangwei Hu | Z. Tao | Qingquan Hua | Cheng Chen
[1] S. Willems,et al. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2 , 2015, Head & neck.
[2] Marsha A. Moses,et al. Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer , 2015, Cancer Prevention Research.
[3] B. Cho,et al. A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.
[4] J. McCubrey,et al. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer , 2014, Oncotarget.
[5] Shun-Fa Yang,et al. Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells , 2013, The Prostate.
[6] N. Zengi̇n,et al. Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[7] C. Butterfield,et al. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] C. H. Lin,et al. Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer. , 2012, Oral diseases.
[9] L. Lund,et al. No Effect of NGAL/lipocalin-2 on Aggressiveness of Cancer in the MMTV-PyMT/FVB/N Mouse Model for Breast Cancer , 2012, PloS one.
[10] A. Takahashi,et al. Therapeutic strategies for head and neck cancer based on p53 status. , 2012, Experimental and therapeutic medicine.
[11] M. Zanetti,et al. Lipocalin 2 in cancer: when good immunity goes bad. , 2012, Cancer letters.
[12] Yun Wu,et al. Relationships of lipocalin 2 with breast tumorigenesis and metastasis , 2011, Journal of cellular physiology.
[13] T. Mak,et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.
[14] H. Brenner,et al. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.
[15] R. Tohtong,et al. NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation , 2010, Clinical & Experimental Metastasis.
[16] J. Cowland,et al. Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ* , 2010, The Journal of Biological Chemistry.
[17] T. Mak,et al. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis , 2010, Proceedings of the National Academy of Sciences.
[18] G. Rice,et al. Neutrophil gelatinase‐associated lipocalin (NGAL) an early‐screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor‐induced epithelio‐mesenchymal transition , 2007, International journal of cancer.
[19] Zhong-ying Shen,et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion , 2006, Journal of Clinical Pathology.
[20] D. Ovcharenko,et al. Neutrophil gelatinase-associated lipocalin as a survival factor. , 2005, The Biochemical journal.
[21] Li Yan,et al. The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients , 2005, Clinical Cancer Research.
[22] R. Strong,et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.
[23] Y. Oshika,et al. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.
[24] T. Kaçan,et al. Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[25] E. Li,et al. Shortest path analyses in the protein-protein interaction network of NGAL (neutrophil gelatinase-associated lipocalin) overexpression in esophageal squamous cell carcinoma. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[26] A. Leonardi,et al. NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells. , 2013, The Journal of clinical endocrinology and metabolism.